ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698931; 2) Community: the network communities that were significantly associated with the response to NSC 698931; 3) Molecule: the relationships between components within communities and NSC 698931; 4) MDR: the compounds that were significantly associated with the NSC 698931.

NSC Compound Enrichment Correlation
NSC 750746 (E)-1-(3,4-dimethoxyphenyl)-3-(2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one 0.00714731931708452 0.36802968
NSC 754242 6-(2-(dimethylamino)ethoxy)-9-methoxy-11H-indeno[1,2-c]quinolin-11-one 0.00714731931708452 0.48980546
NSC 762934 Null 0.00714731931708452 -0.34682382
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.00770426557728501 0.39230834
NSC 129518 Cyclopyrethrosin 0.00770426557728501 0.35831712
NSC 134725 K-33 0.00770426557728501 0.53276369
NSC 222722 Null 0.00770426557728501 0.24168915
NSC 255111 19-Formylgeldanamycin N-piperidinoimine 0.00770426557728501 0.32967287
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00770426557728501 0.46760653
NSC 328785 ANTINEOPLASTIC-328785 0.00770426557728501 0.27940946
Total:202  Current:67    [First] [Prev] [Next] [Last]